Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
2.
Cell Death Differ ; 22(1): 74-85, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25146929

ABSTRACT

Perforin-mediated cytotoxicity is an essential host defense, in which defects contribute to tumor development and pathogenic disorders including autoimmunity and autoinflammation. How perforin (PFN) facilitates intracellular delivery of pro-apoptotic and inflammatory granzymes across the bilayer of targets remains unresolved. Here we show that cellular susceptibility to granzyme B (GzmB) correlates with rapid PFN-induced phosphatidylserine externalization, suggesting that pores are formed at a protein-lipid interface by incomplete membrane oligomers (or arcs). Supporting a role for these oligomers in protease delivery, an anti-PFN antibody (pf-80) suppresses necrosis but increases phosphatidylserine flip-flop and GzmB-induced apoptosis. As shown by atomic force microscopy on planar bilayers and deep-etch electron microscopy on mammalian cells, pf-80 increases the proportion of arcs which correlates with the presence of smaller electrical conductances, while large cylindrical pores decline. PFN appears to form arc structures on target membranes that serve as minimally disrupting conduits for GzmB translocation. The role of these arcs in PFN-mediated pathology warrants evaluation where they may serve as novel therapeutic targets.


Subject(s)
Apoptosis , Cell Membrane Permeability , Cell Membrane/chemistry , Granzymes/chemistry , Multiprotein Complexes/chemistry , Perforin/chemistry , Antibodies, Neutralizing/chemistry , Cell Membrane/metabolism , Humans , Jurkat Cells , Necrosis/metabolism , Protein Transport
5.
Cancer Biother Radiopharm ; 16(1): 85-92, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11279801

ABSTRACT

The expression of CD40L was investigated in HD involved lymph nodes by flow cytometry (FCM) and reverse transcriptase polymerase chain reaction (RT-PCR). Also an investigation of the role of CD40L in upregulation of the anti-apoptotic gene BclxL in a Hodgkin's disease (HD) derived cell line was undertaken. HD patients (n = 18) had significantly higher numbers of activated CD4+ and CD8+ T cells in the tumor microenvironment as compared to controls (n = 8). HD patients also demonstrated higher numbers of CD4+, CD8+ and CD19+ lymphocytes co-expressing CD40L as compared to controls. The CD40L signal was consistently and significantly upregulated in HD patients (n = 5) as compared to controls (n = 3) at the mRNA level. RT-PCR and FCM analysis revealed that soluble CD40L upregulated BclxL levels in the Fas-sensitive HD cell line HDLM2. We conclude that CD40L can act as an important anti-apoptotic molecule by upregulating BclxL expression in Reed-Sternberg cells of HD and may be partly responsible for their survival 'in-vivo'.


Subject(s)
Apoptosis/physiology , CD40 Ligand/physiology , Hodgkin Disease/pathology , Neoplasm Proteins/physiology , Reed-Sternberg Cells/metabolism , Flow Cytometry , Gene Expression Regulation, Neoplastic , Humans , Lymph Nodes/metabolism , Lymph Nodes/pathology , Lymphocyte Activation , Lymphocytes, Tumor-Infiltrating/immunology , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Polymerase Chain Reaction , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/genetics , Pseudolymphoma/metabolism , Pseudolymphoma/pathology , Recombinant Proteins , T-Lymphocyte Subsets/immunology , Tumor Cells, Cultured , bcl-X Protein
6.
Am J Hematol ; 65(2): 105-10, 2000 Oct.
Article in English | MEDLINE | ID: mdl-10996826

ABSTRACT

We have correlated the serum levels of TNF alpha and soluble TNF receptor superfamily members with clinico-pathologic parameters in patients of Hodgkin's disease (HD, N = 26) and non-Hodgkin's lymphoma (NHLs, N = 35). HD patients had significantly higher levels of TNF alpha, sTNFRI, and sTNFRII in serum while NHL patients had significantly higher levels of sTNFRI, sTNFRII, sCD27, and sFas as compared to controls. In NHL patients the levels of sCD27 correlated directly and significantly with the high-stage disease, bone marrow involvement, lymph nodal presentation, and serum LDH levels. Similarly in NHL patients, levels of sFas also correlated directly and significantly with the presence of high stage disease. HD patients with B symptoms had significantly higher levels of sTNFRII.


Subject(s)
Lymphoma/blood , Receptors, Tumor Necrosis Factor/blood , Tumor Necrosis Factor-alpha/metabolism , Adolescent , Adult , Child , Child, Preschool , Female , Hodgkin Disease/blood , Humans , Lymphoma/classification , Lymphoma/pathology , Lymphoma, Non-Hodgkin/blood , Lymphoma, Non-Hodgkin/pathology , Male , Middle Aged , Neoplasm Proteins/metabolism , Neoplasm Staging , Solubility , Tumor Necrosis Factor Receptor Superfamily, Member 7/blood , fas Receptor/blood
7.
Exp Cell Res ; 255(1): 18-29, 2000 Feb 25.
Article in English | MEDLINE | ID: mdl-10666330

ABSTRACT

We investigated whether cell-permeable, synthetic ceramide (C6 ceramide) could induce apoptosis in Fas-resistant Hodgkin's disease (HD)-derived cell lines. Despite strongly expressing the Fas-receptor, two of three HD-derived cell lines were resistant to Fas-mediated apoptosis. This resistance to Fas could not be attributed to differential Fas isoform generation patterns between the Fas-resistant and the Fas-sensitive cell lines. The Fas-resistant cell lines did not demonstrate the presence of Fas exon 8 deletion. Bcl-2 and BclxL levels were comparable between the Fas-resistant and the Fas-sensitive cell lines. C6 ceramide could induce apoptosis in both Fas-resistant cell lines and this was associated with a decrease in BclxL level. Caspase-1, caspase-3, or pan-caspase inhibitors could not prevent ceramide-induced apoptosis. Furthur, ceramide treatment did not lead to cleavage of caspase 3 or poly(ADP-ribose) polymerase, but caused a loss in mitochondrial transmembrane potential which could not be prevented by caspase inhibitors. Thus, we conclude that ceramide-induced apoptosis in Fas-resistant HD cell lines is caspase independent.


Subject(s)
Apoptosis , Caspase 1/metabolism , Caspases/metabolism , Ceramides/metabolism , Hodgkin Disease/metabolism , fas Receptor/metabolism , Amino Acid Chloromethyl Ketones/pharmacology , CD40 Antigens/metabolism , Caspase 3 , Caspase Inhibitors , Cell Membrane Permeability , Ceramides/pharmacology , Cysteine Proteinase Inhibitors/pharmacology , Enzyme Inhibitors/pharmacology , Fas Ligand Protein , Gene Expression , Humans , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Okadaic Acid/pharmacology , Oligopeptides/pharmacology , Poly(ADP-ribose) Polymerases/metabolism , Proto-Oncogene Proteins c-bcl-2/genetics , Tetradecanoylphorbol Acetate/pharmacology , Tumor Cells, Cultured , Up-Regulation , bcl-X Protein , fas Receptor/genetics
8.
Leuk Lymphoma ; 33(5-6): 521-30, 1999 May.
Article in English | MEDLINE | ID: mdl-10342579

ABSTRACT

Fas and Fas ligand expression were investigated in twenty two cases of classical Hodgkin's disease (HD) by immunohistochemistry. While Reed-Sternberg (RS) cells in 7/22 (32%) cases expressed Fas ligand, reactive lymphoid cells expressed Fas ligand in only 2 (9%) cases. In 20/22 (91%) cases, the RS cells expressed Fas. A higher proportion of RS cells in the nodular sclerosis subtype expressed Fas as compared to the mixed cellularity subtype. In 18/22 (82%) cases, Fas expression was also noted in the reactive lymphoid cells. In eight cases, the reactive lymphoid cells were also analyzed by flow cytometry and a majority of them were CD4+CD45RO+. Most of these activated T-cells expressed Fas but were negative for Fas Ligand. To investigate the co-expression of Fas and Fas Ligand in the RS cells, six cases were subjected to Fas and Fas ligand immunostaining on consecutive sections. The co-expression was documented in the RS cells in four of six cases. These six cases with expression of both Fas and Fas ligand were investigated for the incidence of apoptosis. There was no statistically significant relationship between expression of Fas on reactive cells, expression of FasL on RS cells and the proportion of apoptotic reactive cells. In all these cases apoptosis was not observed in the RS cells. Thus Fas - FasL interactions may not lead to apoptosis of the RS cells.


Subject(s)
Apoptosis , Hodgkin Disease/metabolism , Membrane Glycoproteins/biosynthesis , fas Receptor/biosynthesis , Fas Ligand Protein , Flow Cytometry , Hodgkin Disease/immunology , Hodgkin Disease/pathology , Humans , Immunohistochemistry , Lymph Nodes/immunology , Lymph Nodes/metabolism , Lymph Nodes/pathology
9.
Anal Biochem ; 267(2): 382-9, 1999 Feb 15.
Article in English | MEDLINE | ID: mdl-10036145

ABSTRACT

A procedure was developed to estimate protein concentrations using color image analysis of protein spots stained with ponceau S. The method involved spotting a constant volume (2 microl) of the protein solutions on nitrocellulose paper, staining with acidic ponceau S, destaining, and air drying the paper. The image of the nitrocellulose paper was grabbed using a digital color scanner and thresholded with an optimal value to mark the area of the spot. The intensity of the color in the spot was measured in an arbitrary unit of intensity termed as inverse integrated gray value. This value showed a discernible increase with protein concentrations from 0.1 to 50 microg protein per spot (0.05-25 mg/ml). The method is simple and convenient compared to the conventional spectrophotometric procedures and allows several samples to be analyzed simultaneously. It can also be used to estimate protein concentration in the spots stained with Coomassie brilliant blue or other dyes.


Subject(s)
Proteins/analysis , Collodion , Color , Image Processing, Computer-Assisted
10.
Cancer Immunol Immunother ; 47(2): 104-12, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9769119

ABSTRACT

Modulation of Fas expression and function by CD40 ligation was investigated in the Fas-sensitive human Hodgkin's disease cell line HDLM2. The recombinant human trimeric soluble CD40L (sCD40L) protected this cell line from apoptosis induced by an agonistic Fas antibody at all concentrations tested. sCD40L also protected HDLM2 when added up to 2 h after Fas ligation. Apoptosis induced by a cell-permeable synthetic ceramide could not be prevented by sCD40L. Thus, CD40 ligation is likely to intervene in the early phases of the Fas signal transduction pathway. When CD40 ligation preceded Fas ligation, it rendered the cells refractory to Fas-induced apoptosis. sCD40L-mediated protection could not be attributed to reduction in surface Fas expression, increase in Bcl-2 levels or to increase in the levels of soluble Fas isoforms.


Subject(s)
Apoptosis/physiology , CD40 Antigens/physiology , Hodgkin Disease/pathology , CD40 Antigens/biosynthesis , CD40 Antigens/metabolism , CD40 Ligand , Fas Ligand Protein , Hodgkin Disease/immunology , Hodgkin Disease/metabolism , Humans , Isomerism , Kinetics , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Receptors, Tumor Necrosis Factor/metabolism , Tumor Cells, Cultured , fas Receptor/biosynthesis , fas Receptor/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...